Frontlight ResearchEarly access
WithdrawnPhase 2
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use
Key facts
- Who runs it
- M.D. Anderson Cancer Center
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 2
- Started
- 25 Oct 2022
- Ended
- 9 May 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- IPAD
- Augmented Reality
- Record updated
- 23 October 2024
- Why it stopped
- No Patients Enrolles
Who can take part
- Age
- 5 years to 15 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Ages 5-15
- English and Spanish-speaking parents/legal guardians and patients
- Undergoing surgery requiring postoperative hospitalization is defined as ≥2 hours of duration of surgery and requiring postoperative hospital admission of at least one night
- Expected to be prescribed postoperative inpatient opioids
- Prescribed daily opioids for pain for a period equal to or longer than 30 days before surgery
- Sufficient cognitive capacity to comprehend and interact with the game. This is defined as the ability to utilize mobile technology (use iPad with or without assistance) and activate and respond to AR experiences within the app as determined by the clinician
- Both the child and a legal guardian are willing and able to provide informed consent; The range from 5-to 15 is based on a recent pilot RCT in which the PI found that older adolescents (>15 years of age) were disinterested in the interactive game
Who cannot take part
- Have never taken opioids or have had no daily opioid use within the last 30 days before surgery
- Any additional concerns based on the study physicians' assessments b. Setting: Academic tertiary cancer center: University of Texas - MD Anderson Cancer Center and Baylor College of Medicine - Texas Children's Hospital
- Inability to demonstrate an understanding of the game from English instructions
Where in United States
- MD Anderson Cancer CenterHouston, United States
About the trial
What the trial wants to find out
Tto learn if playing an augmented reality game called SpellBound can reduce pain and the need for opioids in young patients following surgery.
The 2 groups in the trial
- Group 1 (Spellbound)Treatment being tested
Participants will play SpellBound using the iPad's standard camera, which will show you your hospital room and the decal/stickers s as they appear in the real world.
Treatment: IPAD
- Group 2 (Spellbound)Treatment being tested
Participants will play the game using augmented reality.
Treatment: Augmented Reality
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 October 2024